Market Overview

Benzinga's Top Pre-Market Gainers

Share:
Related LXRX
Buy/High Risk Rating Given To Lexicon Pharmaceuticals By Citi Analysts
Every Biotech Catalyst Wedbush Is Watching In 2016
Related ARIA
Watch These 7 Huge Call Purchases In Tuesday Trade
Technical Alert: Finding Resistance In Ariad Pharmaceuticlas After Q2 Report
Under New Structure, ARIAD Growth Opportunities May Be Undervalued (Seeking Alpha)

Lexicon Pharmaceuticals (NASDAQ: LXRX) surged 10.70% to $2.07 in the pre-market session. Lexicon Pharmaceuticals reported that it has received "Fast Track" status from the FDA for the development of LX1033.

Ariad Pharmaceuticals (NASDAQ: ARIA) added 3.48% to $19.59 in the pre-market session. ARIAD Pharmaceuticals reported that the FDA has granted accelerated approval of Iclusig™ (ponatinib).

American Capital Agency (NASDAQ: AGNC) moved up 2.85% to $31.06 in the pre-market session. American Capital Agency declared a Q4 cash dividend of $1.25 per common share.

Sprint Nextel (NYSE: S) soared 2.16% to $5.67 in the pre-market trading. Sprint will acquire the approximately 50% stake in Clearwire (NASDAQ: CLWR) it does not currently own for $2.97 per share.

Posted-In: Top Pre-Market GainersNews Pre-Market Outlook Markets Movers

 

Related Articles (AGNC + ARIA)

View Comments and Join the Discussion!